(2S,4R)-4-Aminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester is a chiral, non-natural amino acid derivative featuring a pyrrolidine ring scaffold. It is characterized by a cis-configured 2,4-disubstituted pyrrolidine structure, with a free amino group at the 4-position and a carboxylic acid group at the 2-position, while the other nitrogen is protected as a tert-butyl carbamate (Boc). This specific stereochemistry ((2S,4R)) is crucial for its biological activity and application. This compound serves as a key chiral building block and advanced intermediate in pharmaceutical synthesis. Its primary application is in the development of protease inhibitors, particularly for HIV-1. The (2S,4R) stereoisomer is a critical component in the synthesis of potent HIV protease inhibitors, such as Atazanavir and other related drugs. The pyrrolidine core mimics the transition state of peptide hydrolysis, and the free amino and carboxylic acid groups allow for further derivatization and incorporation into larger, more complex drug molecules. As a bifunctional synthon, it is widely utilized in medicinal chemistry for constructing peptidomimetics and exploring structure-activity relationships (SAR). Its Boc-protected amine and free carboxylic acid offer orthogonal reactivity for sequential coupling reactions. Due to its high value and specific configuration, it is typically handled under controlled conditions and is considered a non-bulk, high-purity research chemical.